10:12 AM EST - Medicago Inc. : announced the successful completion of the first stage of its research collaboration, announced initially on April 6, with a top-10 global pharmaceutical company for the development of a non-influenza VLP vaccine candidate. Medicago's collaboration partner has indicated its intent to proceed to the second stage of the agreement. Medicago Inc.
shares T.MDG are trading up $0.01 at $0.62.
